This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.
| less than a minute read

NHS England publishes Commercial Framework for New Medicines

The pharmaceutical industry now has some clarity around the NHS’ approach to commercial activity in relation to branded medicines.  This framework had been expected last year however.

The commercial framework: - outlines the purpose and principles on which NHS commercial medicines activity will be based. - defines the roles and responsibilities of those involved in commercial medicines activity and detailing how pharmaceutical companies can engage with the NHS. - clarifies the routes to routine commissioning in the NHS, and where commercial activity can occur in those routes. - outlines commercial flexibilities, and circumstances where they could be considered.

Subscribe to receive our latest insights - on the topics that matter most to you - direct to your inbox, at your preferred frequency. Subscribe here

Tags

life sciences, life sciences regulatory